The value of metabolic parameters on dynamic 18F-FDG PET/CT for predicting lymph node metastasis in non-small cell lung cancer
Open Access
- 12 February 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1752947
Abstract
Objectives: To evaluate the predictive value of dynamic 18 F-FDG PET/CT metabolic parameters of the primary tumor for mediastinal lymph node metastasis (LNM) in non-small cell lung cancer (NSCLC). Methods: A total of 316 patients with clinically suspected but untreated lung lesions who underwent dynamic PET/CT and static PET/CT scans from May 2021 to November 2024 were retrospectively collected in this study. Quantitative parameters including K1, k2, k3, and Ki of each lesion, were obtained by applying the irreversible two-tissue compartmental modeling using an in-house Matlab software. Time-activity curves (TACs) at the primary tumor were extracted from each dynamic 18 F-FDG PET/CT scan. The TAC signal was then decomposed into metabolism and blood flow components through kinetic modeling. Dynamic features including area under the curve (AUC), time-to-peak (t peak ), and slopes were then extracted from each component. Predictive analyses were performed using multivariate logistic regression to determine the predictive factors for LNM. Receiver-operating characteristic (ROC) analysis was performed to evaluate the predictive performance of models. Results: One hundred and fifteen patients who obtained LN biopsy within one month were enrolled in this study. Based on the results of the pathology, the patients were divided into LNM and non-LNM groups. The multivariate logistic regression analyses showed that the TLG, slope 10-30min , and CA125 were independent predictive factors for LNM ( P < 0.05, respectively). For the model comparison, composite model achieved the highest diagnostic efficacy (AUC of 0.867, sensitivity 75.5%, specificity 84.5%, accuracy 80.2%) compared with PET/CT model (AUC of 0.822, sensitivity 80.0%, specificity 72.4%, accuracy 75.7%) and clinical model (AUC of 0.792, sensitivity 49.1%, specificity 96.7%, accuracy 73.9%). Conclusion: The metabolic parameters based on dynamic and static 18 F-FDG PET/CT combined with CA125 can improve N-staging accuracy in patients with NSCLC.Keywords
This publication has 30 references indexed in Scilit:
- Leveraging machine learning with dynamic 18F-FDG PET/CT: integrating metabolic and flow features for lung cancer differential diagnosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysisLung Cancer, 2019
- Prediction of occult lymph node metastasis using SUV, volumetric parameters and intratumoral heterogeneity of the primary tumor in T1-2N0M0 lung cancer patients staged by PET/CTAnnals of Nuclear Medicine, 2019
- Dynamic whole-body PET imaging: principles, potentials and applicationsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on 18F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node InvolvementClinical Lung Cancer, 2018
- Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer DatabaseThe Annals of Thoracic Surgery, 2017
- Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- Metabolic parameters using 18F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Accuracy of FDG-PET to Diagnose Lung Cancer in a Region of Endemic Granulomatous DiseaseThe Annals of Thoracic Surgery, 2011
- Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)Clinical Lung Cancer, 2011